Mass spectrometric quantitation assay for metabolites of leflunomide Grant US-11879900-B2 United States of America 23 Jan 2024
Mass spectrometric quantitation assay for metabolites of leflunomide Grant US-11333673-B2 United States of America 17 May 2022
Mass spectrometric quantitation assay for metabolites of leflunomide Grant US-10598676-B2 United States of America 24 Mar 2020
COMPOSITION FOR TREATING MULTIPLE SCLEROSIS Application EA-028308-B1 Eurasian Patent Organisation 30 Nov 2017
Mass spectrometric quantitation for metabolites of leflunomide Grant US-9817005-B2 United States of America 14 Nov 2017
Mass spectrometric quantitation assay for metabolites of leflunomide Application US-9177766-B2 United States of America 03 Nov 2015
COMPOSITION FOR TREATING MULTIPLE SCLEROSIS (VARIANTS) Application WO-2013184023-A1 World Intellectual Property Organisation (WIPO) 12 Dec 2013
MASS SPECTROMETRIC QUANTITATION ASSAY FOR METABOLITES OF LEFLUNOMIDE Application US-20120171151-A1 United States of America 05 Jul 2012
AMINO-BENZOIC ACID DERIVATIVES FOR USE IN THE TREATMENT OF DIHYDROGENASE-RELATED DISORDERS Application WO-2011053468-A1 World Intellectual Property Organisation (WIPO) 05 May 2011
Use of the combination of teriflunomide and interferon beta for treating multiple… Application EP-2277515-A1 European Patent Office 26 Jan 2011
USE OF THE COMBINATION OF TERIFLUNOMIDE AND INTERFERON BETA FOR TREATING MULTIPLE… Application WO-2011005907-A1 World Intellectual Property Organisation (WIPO) 13 Jan 2011